Suppr超能文献

尼可地尔预处理对肝移植患者的脑保护作用。

Cerebral protective effect of nicorandil premedication on patients undergoing liver transplantation.

机构信息

Department of Anesthesiology, Shanghai First People's Hospital, Medical College, Shanghai Jiaotong University, Shanghai 200080, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2012 Apr;11(2):132-6. doi: 10.1016/s1499-3872(12)60137-4.

Abstract

BACKGROUND

Neurological injury is a common complication in the early period after liver transplantation, posing an enormous obstacle to treatment efficiency and patient survival. Nicorandil is a mitochondrial ATP-sensitive potassium channel (mitoKATP) opener. It has been reported to be effective in reducing brain injury in recent studies. However, it is still unclear whether nicorandil has cerebral protective effect in patients undergoing liver transplantation.

METHODS

Fifty patients scheduled for liver transplantation were randomly divided into a nicorandil group (group N) (n=25), in which patients received 10 mg nicorandil through a nasogastric tube 30 minutes before induction of anesthesia, and a control group (group C) (n=25) who received 10 mL normal saline. The Mini-Mental State Examination (MMSE) was performed before anesthesia (day 0), and on days 3 and 7 after surgery. Blood samples were obtained before induction of anesthesia (T1), and at 12 (T2) and 36 hours (T3) after surgery for determination of serum neuron-specific enolase (NSE) and S100β protein (S100β) concentrations.

RESULTS

During surgery, 5 patients in each group were eliminated due to severe reperfusion or renal insufficiency. Therefore, 20 patients remained in each group. The MMSE scores after operation were significantly lower than those before operation in group C. However, there was no difference at days 3 and 7 compared with day 0 in group N. Serum NSE concentrations after surgery were significantly higher than baseline (at T1) in both groups, except at T3 in group N. Serum S100β concentration after surgery was significantly higher than baseline (at T1) in both groups. The MMSE scores at days 3 and 7 in group N were significantly higher than those in group C. The concentrations of serum NSE and S100β at T2 and T3 in group N were significantly lower than those in group C.

CONCLUSIONS

Oral nicorandil, as a premedication before liver transplantation, improves postoperative MMSE scores. It also attenuates the increase of NSE and S100β in blood, indicating its cerebral protective effect.

摘要

背景

神经损伤是肝移植后早期的常见并发症,极大地影响了治疗效果和患者生存率。尼可地尔是一种线粒体三磷酸腺苷敏感性钾通道(mitoKATP)开放剂。最近的研究表明,它在减轻脑损伤方面具有一定的效果。然而,尼可地尔对接受肝移植的患者是否具有脑保护作用尚不清楚。

方法

50 例行肝移植的患者被随机分为尼可地尔组(N 组)(n=25)和对照组(C 组)(n=25)。在麻醉诱导前 30 分钟,N 组患者通过鼻胃管给予 10mg 尼可地尔,C 组患者给予 10ml 生理盐水。在麻醉前(第 0 天)、术后第 3 天和第 7 天进行简易精神状态检查(MMSE)。在麻醉诱导前(T1)和术后 12 小时(T2)和 36 小时(T3)时采集血样,测定血清神经元特异性烯醇化酶(NSE)和 S100β 蛋白(S100β)浓度。

结果

每组有 5 例患者因严重再灌注或肾功能不全而被排除,因此每组各有 20 例患者。与 C 组相比,N 组术后 MMSE 评分明显低于术前。然而,与第 0 天相比,N 组在术后第 3 天和第 7 天并无差异。两组术后血清 NSE 浓度均明显高于基础值(T1),但 N 组在 T3 时除外。两组术后血清 S100β浓度均明显高于基础值(T1)。N 组术后第 3 天和第 7 天的 MMSE 评分明显高于 C 组。N 组 T2 和 T3 时的血清 NSE 和 S100β浓度明显低于 C 组。

结论

肝移植前口服尼可地尔可改善术后 MMSE 评分,减轻 NSE 和 S100β 血浓度升高,提示其具有脑保护作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验